1. Home
  2. PGY vs IOVA Comparison

PGY vs IOVA Comparison

Compare PGY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGY
  • IOVA
  • Stock Information
  • Founded
  • PGY 2016
  • IOVA 2007
  • Country
  • PGY United States
  • IOVA United States
  • Employees
  • PGY N/A
  • IOVA N/A
  • Industry
  • PGY Finance: Consumer Services
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PGY Finance
  • IOVA Health Care
  • Exchange
  • PGY Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • PGY 863.7M
  • IOVA 771.4M
  • IPO Year
  • PGY N/A
  • IOVA N/A
  • Fundamental
  • Price
  • PGY $18.47
  • IOVA $1.98
  • Analyst Decision
  • PGY Strong Buy
  • IOVA Buy
  • Analyst Count
  • PGY 8
  • IOVA 10
  • Target Price
  • PGY $21.44
  • IOVA $12.22
  • AVG Volume (30 Days)
  • PGY 2.0M
  • IOVA 11.2M
  • Earning Date
  • PGY 08-08-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • PGY N/A
  • IOVA N/A
  • EPS Growth
  • PGY N/A
  • IOVA N/A
  • EPS
  • PGY N/A
  • IOVA N/A
  • Revenue
  • PGY $1,076,961,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • PGY $20.61
  • IOVA $86.62
  • Revenue Next Year
  • PGY $13.33
  • IOVA $69.95
  • P/E Ratio
  • PGY N/A
  • IOVA N/A
  • Revenue Growth
  • PGY 23.69
  • IOVA 11070.12
  • 52 Week Low
  • PGY $8.20
  • IOVA $1.64
  • 52 Week High
  • PGY $19.20
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • PGY 64.13
  • IOVA 43.44
  • Support Level
  • PGY $18.10
  • IOVA $1.95
  • Resistance Level
  • PGY $19.04
  • IOVA $2.47
  • Average True Range (ATR)
  • PGY 0.83
  • IOVA 0.15
  • MACD
  • PGY -0.06
  • IOVA 0.05
  • Stochastic Oscillator
  • PGY 79.08
  • IOVA 35.53

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: